QIAGEN N.V.: Release of a capital market information

DGAP Post-admission Duties announcement: QIAGEN N.V. / Share Buyback QIAGEN N.V.: Release of a capital market information 19.02.2019 / 10:44 Dissemination of a Post-admission Duties announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. Disclosure according to Article 5 Section (1) and (6) of the EU Regulation 596/2014 in conjunction with Article 2 Section (2) and (3) of the Delegated EU Regulation 2016/1052 / Share Repurchase - Interim Reporting With disclosure dated December 19, 2018, QIAGEN N.V. announced pursuant to Article 5 Section (1) and (6) of the EU Regulation no 596/2014 and Article 2 Section (1) of the Delegated EU Regulation no 2016/1052 the immediate beginning of a third tranche of up to USD 70 million under the share repurchase program originally announced on January 31, 2018. The number of shares which have been bought back on the electronic trading platform of the Frankfurt Stock Exchange (XETRA) within the framework of such tranche of the share repurchase program in the time period from February 11, 2019 until and including February 15, 2019 amounts to 120,341 shares. Shares were bought back as follows: Date Number of Shares Average Price Purchased Volume acquired (EUR) (EUR) 11 February 2019 24,573 32.5152 798,996.01 12 February 2019 24,372 32.7822 798,967.78 13 February 2019 24,337 32.8296 798,973.98 14 February 2019 23,575 33.8912 798,985.04 15 February 2019 23,484 34.0218 798,967.95 Total 120,341 33.1964 3,994,890.75 The underlying individual trades are published on the website of QIAGEN N.V. (http://corporate.qiagen.com/investor-relations/share-information/ share-buyback). The total number of shares which have already been bought back within the framework of such tranche of the share repurchase program from December 19, 2018 until and including February 15, 2019 amounts to 1,013,450 shares. The purchase of the shares of QIAGEN N.V. was carried out by a financial institution that has been commissioned by QIAGEN N.V. Venlo, 19 February 2019 Managing Board ### Contacts: QIAGEN Investor Relations John Gilardi [phone] e-mail: [e-mail] Public Relations Dr. Thomas Theuringer [phone] e-mail: [e-mail] 19.02.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language:	English
Company:	QIAGEN N.V.
	Hulsterweg 82
	5912 PL Venlo
	Netherlands
Internet:	www.qiagen.com

End of News	DGAP News Service

777343  19.02.2019